256 related articles for article (PubMed ID: 21318604)
41. A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion.
Bhargava R; Chakravarti A
Am J Otolaryngol; 2014; 35(6):766-70. PubMed ID: 25151658
[TBL] [Abstract][Full Text] [Related]
42. Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants.
Marple BF; Smith TL; Han JK; Gould AR; Jampel HD; Stambaugh JW; Mugglin AS
Otolaryngol Head Neck Surg; 2012 Jun; 146(6):1004-11. PubMed ID: 22301107
[TBL] [Abstract][Full Text] [Related]
43. Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps.
Shikani AH; Kourelis K; Alqudah MA; Shikani HJ; Cope E; Kirk N; Bergstedt D; Basaraba RJ; Leid JG
Clin Otolaryngol; 2013 Jun; 38(3):254-8. PubMed ID: 23398898
[No Abstract] [Full Text] [Related]
44. Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis.
Pitsios C; Papadopoulos D; Kompoti E; Manoussakis E; Garris V; Petalas K; Tassios I; Baibas N; Kontou-Fili K; Saxoni-Papageorgiou P; Papadopoulos NG
Ann Allergy Asthma Immunol; 2006 May; 96(5):673-8. PubMed ID: 16729779
[TBL] [Abstract][Full Text] [Related]
45. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis.
Small CB; Stryszak P; Danzig M; Damiano A
J Allergy Clin Immunol; 2008 Apr; 121(4):928-32. PubMed ID: 18234321
[TBL] [Abstract][Full Text] [Related]
46. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study.
Stjärne P; Blomgren K; Cayé-Thomasen P; Salo S; Søderstrøm T
Acta Otolaryngol; 2006 Jun; 126(6):606-12. PubMed ID: 16720445
[TBL] [Abstract][Full Text] [Related]
47. Role of mometasone furoate aqueous nasal spray for management of adenoidal hypertrophy in children.
Bhargava R; Chakravarti A
J Laryngol Otol; 2014 Dec; 128(12):1060-6. PubMed ID: 25404102
[TBL] [Abstract][Full Text] [Related]
48. Summaries for patients: Initial treatment with oral steroids for chronic sinusitis accompanied by nasal polyps.
Ann Intern Med; 2011 Mar; 154(5):I34. PubMed ID: 21357904
[No Abstract] [Full Text] [Related]
49. [The effect of mometasone furoate on mucociliary clearance in patients with perennial allergic rhinitis].
Pata YS; Akbaş Y; Unal M; Görür K; Ozcan C; Vayisoğlu Y
Kulak Burun Bogaz Ihtis Derg; 2003 Oct; 11(4):97-9. PubMed ID: 15493336
[TBL] [Abstract][Full Text] [Related]
50. Is mometasone furoate aqueous nasal spray (MFNS) effective in reducing symptoms in acute recurrent sinusitis?
McConaghy JR
J Fam Pract; 2001 Feb; 50(2):107. PubMed ID: 11219553
[No Abstract] [Full Text] [Related]
51. Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps.
Vuralkan E; Saka C; Akin I; Hucumenoglu S; Unal BU; Kuran G; Ocal B
Ther Adv Respir Dis; 2012 Feb; 6(1):5-10. PubMed ID: 22042749
[TBL] [Abstract][Full Text] [Related]
52. Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis.
Berger WE; Nayak AS; Staudinger HW
Ann Pharmacother; 2005 Dec; 39(12):1984-9. PubMed ID: 16278257
[TBL] [Abstract][Full Text] [Related]
53. Preoperative treatment with topical corticoids and bleeding during primary endoscopic sinus surgery.
Albu S; Gocea A; Mitre I
Otolaryngol Head Neck Surg; 2010 Oct; 143(4):573-8. PubMed ID: 20869570
[TBL] [Abstract][Full Text] [Related]
54. Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis.
Giger R; Pasche P; Cheseaux C; Cantini L; Rossetti A; Landis BN; Lacroix JS
Eur Arch Otorhinolaryngol; 2003 Mar; 260(3):135-40. PubMed ID: 12687385
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps.
Tatar EÇ; Tatar I; Ocal B; Korkmaz H; Saylam G; Ozdek A; Celik HH
Otolaryngol Head Neck Surg; 2012 Apr; 146(4):669-75. PubMed ID: 22241786
[TBL] [Abstract][Full Text] [Related]
56. A patient preference and satisfaction study of ciclesonide nasal aerosol and mometasone furoate aqueous nasal spray in patients with perennial allergic rhinitis.
Berger WE; Prenner B; Turner R; Meltzer EO
Allergy Asthma Proc; 2013; 34(6):542-50. PubMed ID: 24169063
[TBL] [Abstract][Full Text] [Related]
57. [Steroid sprays in non-infectious rhinitis and sinusitis. Proper and regular spraying does not damage the nasal mucosa].
Klimek L; Bachert C; Hörmann K
MMW Fortschr Med; 2002 Mar; 144(10):41-3. PubMed ID: 11928263
[TBL] [Abstract][Full Text] [Related]
58. [Intranasal steroid therapy in inflammatory nasal-sinus pathology in pediatric age].
Berlucchi M; Tomenzoli D
Minerva Pediatr; 2009 Jun; 61(3):323-31. PubMed ID: 19461575
[TBL] [Abstract][Full Text] [Related]
59. The rhinotopic protocol for chronic refractory rhinosinusitis: how we do it.
Shikani AH; Chahine KA; Alqudah MA
Clin Otolaryngol; 2010 Aug; 35(4):329-32. PubMed ID: 20738346
[No Abstract] [Full Text] [Related]
60. ADVANCE: a multisite trial of bioabsorbable steroid-eluting sinus implants.
Forwith KD; Chandra RK; Yun PT; Miller SK; Jampel HD
Laryngoscope; 2011 Nov; 121(11):2473-80. PubMed ID: 22020898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]